-
公开(公告)号:US11707508B2
公开(公告)日:2023-07-25
申请号:US16679425
申请日:2019-11-11
IPC分类号: A61K38/27 , A61P31/18 , A61K31/52 , A61K31/708 , A61K31/7068 , A61K31/341 , A61K31/675 , A61K31/496 , A61K31/536 , A61K31/505 , A61K31/551 , A61K31/7072
CPC分类号: A61K38/27 , A61K31/341 , A61K31/496 , A61K31/505 , A61K31/52 , A61K31/536 , A61K31/551 , A61K31/675 , A61K31/708 , A61K31/7068 , A61K31/7072 , A61P31/18
摘要: The subject invention pertains to methods of treating HIV-1 infected subject comprising the administration of growth hormone to a subject infected by HIV-1. The subject may be undergoing co-administration of anti-retroviral therapies (ARTs), may be untreated with anti-retroviral drugs (ARDs) or may be in a period of time where no ART is being administered. Growth hormone may be administered at a fixed dosage for a set period of time or may be administered at a first dosage for a first period of time that may then be increased or decreased to a second dosage for a second period of time.